Vantage logo

Nkarta goes back to basics

After a hiatus Nkarta comes back with a new lymphodepletion regimen to boost its lead Car-NK therapy.

Vantage logo

PD-1 versus Car-T: stop making sense

T-cell exhaustion, a frequently cited reason for Car-T relapse, might be reversed by PD-(L)1 blockade; but is exhaustion really the problem?